Table 1 Clinical features of patients in different MM groups before chemotherapy
Clinical features | ND cases (n = 62) | CR&VGPR cases (n = 38) | RR cases (n = 43) |
|---|---|---|---|
Sex | |||
 Male | 34 | 21 | 27 |
 Female | 28 | 17 | 16 |
Age (year) | 56.5 (44–73) | 54.5 (44–71) | 57.5 (45–73) |
WBC (× 109/L) | 5.7 (2.7–14) | 5.3 (3.2–11.5) | 6.2 (2.3–15.3) |
Hb (g/L) | 83 (52–101) | 82 (63–132) | 72 (48–95) |
PLT (× 109/L) | 190 (23–356) | 202 (89–387) | 183 (56–361) |
Subtype | |||
 IgG type | 32 | 20 | 26 |
 IgA type | 12 | 8 | 8 |
 IgM type | 0 | 0 | 0 |
 Light chain type | 8 | 5 | 5 |
 Non-secretory type | 10 | 5 | 4 |
MM cell > 10% | 62 | 38 | 43 |
ESR↑ | 53 | 31 | 36 |
Glb (> 30 g/L) | 52 | 33 | 39 |
Renal failure (serum creatinine ≥ 2 mg/100 mL) | 13 | 6 | 9 |
Hypercalcemia | 15 | 6 | 8 |
Bence-Jone protein | 21 | 5 | 9 |
LDH↑ | 35 | 19 | 28 |
Bone lesions (lytic lesions, pathologic fractures or severe osteopenia) | 50 | 31 | 35 |